(PharmaNewsWire.Com, September 20, 2017 ) Diagnostics tests for viral hepatitis and retrovirus help in screening, diagnosing, and managing diseases in humans. The tests are usually performed in the laboratory under controlled environment. In hepatitis and retrovirus infections, the diagnostic tests provide a valuable health status of patients without having a direct therapeutic effect. Hence, they play a significant role in supporting decision-making in clinical conditions. Advances in diagnostic testing systems and assays have led to the development of self-testing, which are easy to perform and convenient for both medical professionals and patients. The diagnostic tests for viral hepatitis and retrovirus can be carried out in hospitals, clinics, or at home.
The report covers the current scenario and the growth prospects of the global viral hepatitis and retrovirus diagnostic tests market for the period of 2015-2019. To calculate the market size, the report considers revenue generated through the sales of assays and instruments for diagnostic testing of viral hepatitis and retrovirus.
Publisher's report, Global Viral Hepatitis and Retrovirus Diagnostic Tests Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers APAC, Europe, Latin America, MEA, and North America; it also covers the landscape of the market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.
Key regions - APAC - Europe - Latin America - MEA - North America
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including: